OB/GYN Clinical Alert – March 1, 2008
March 1, 2008
View Issues
-
OCs and Endometriosis
Harada and colleagues from Japan conducted a double-blind, placebo-controlled, randomized multicenter trial of a low-dose oral contraceptive for the treatment of dysmenorrhea associated with endometriosis. -
Prevention of Preeclampsia through Administration of Antioxidants
Among various agents that have been used to prevent preeclampsia, the ones that have attracted the greatest attention have been low-dose aspirin, calcium, and vitamins C and E. -
The Value of Expert Ultrasonography
Diagnostic ultrasonography is one of the most frequently utilized adjuvant tools clinicians rely upon to make treatment recommendations for suspect adnexal pathology. -
Therapeutic Vaccination for Dysplasia: Early Efficacy
Heat shock proteins have been of clinical interest in therapeutic vaccination based on their ability to induce significant T- and B-cell responses against microbial pathogens and tumor antigens. -
Special Feature: Opposition to the Timing Hypothesis
The Timing Hypothesis argues that estrogen can reduce the risk of coronary heart disease when administered to relatively young postmenopausal women before atherosclerosis has developed to the stage of unstable plaques (plaques with necrosis and inflammation). -
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: FDA Heightens Warnings on Chantix
In this issue: Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.